Skip to main content

Market Overview

Atara Biotherapeutics (NASDAQ: ATRA)

15.43 -0.22 (-1.41%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/13/21JP MorganUpgradesOverweight29.0
5/05/21HC Wainwright & Co.MaintainsBuy31.0
12/08/20HC Wainwright & Co.MaintainsBuy31.0
11/10/20HC Wainwright & Co.MaintainsBuy28.0
9/15/20Canaccord GenuityMaintainsBuy78.0
8/06/20StifelMaintainsBuy28.0
8/06/20HC Wainwright & Co.MaintainsBuy26.0
6/30/20Evercore ISI GroupInitiates Coverage OnOutperform
6/15/20HC Wainwright & Co.Initiates Coverage OnBuy25.0
5/12/20JP MorganMaintainsNeutral23.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter